Update: BioAffinity Technologies Prices $4 Million Registered Direct Offering
MT newswire2026/10/08 16:5512:55 PM EDT, 10/08/2026 (MT Newswires) -- (Updates with latest stock price.) BioAffinity Technologies (BIAF) said Thursday it entered into a definitive agreement with an institutional investor to sell shares of common stock at $6.122 per share in a registered direct offering. In a concurrent private placement, the company will also sell warrants to purchase up to 980,072 shares at an exercise price of $6.122 per share. The offering is expected to raise gross proceeds of about $4 million, which the company intends to use for working capital, to support sales of CyPath Lung, and for general corporate purposes. The offering is expected to close on Friday. BioAffinity shares were 1.1% higher in Thursday trading. Price: 6.21, Change: +0.05, Percent Change: +0.81
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.
Crypto prices
More
